Search clinical trials for: Antipsychotic Agents

Total 188683 results

University of British Columbia

Withdrawn

Study of the Effect of Dosing on Clozapine Levels (PK-CLZ)

Psychotic Disorders | Schizophrenia

Canada
Peking University Third Hospital

Completed

Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder

Emotional Disorder | Neurologic Disorder

China
Hoffmann-La Roche

Completed

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Schizophrenia, Schizoaffective Disorder

United States, Japan, Ukraine, Russian Federation
Delpor, Inc.
National Institute of Mental Health (NIMH)

Completed

Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone Implant (DLP-114)

Schizophrenia

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia

Schizophrenia

Italy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study

Pyschotic Disorders

Brazil
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

Mexico
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs

Schizophrenia | Schizoaffective Disorder

Taiwan
Centre for Addiction and Mental Health

Unknown

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Canada
Massachusetts General Hospital
Vanderbilt University; Cedars-Sinai Medical Center; University of Connecticut; Cambridge... and other collaborators

Completed

A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder (Geodon)

Major Depressive Disorder

United States
Johnson & Johnson Taiwan Ltd

Completed

An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

Schizophrenia | Schizoaffective Disorders
New York State Psychiatric Institute
Columbia University; National Institute on Aging (NIA)

Completed

Antipsychotic Discontinuation in Alzheimer's Disease (ADAD)

Aggression | Psychotic Disorders | Alzheimer Disease | Agitation

United States
Eli Lilly and Company

Completed

A Study in Schizophrenia Patients

Schizophrenia

United States, Russian Federation, Croatia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

Schizophrenia
Janssen Korea, Ltd., Korea

Completed

The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania

Bipolar Disorder
Capital Medical University

Completed

Risperidone Maintenance Treatment in Schizophrenia

Schizophrenia

China
University of South Florida
Janssen, LP

Completed

A Study of Risperidone Monotherapy in Bipolar Anxiety

Generalized Anxiety Disorder | Bipolar Disorder | Panic Disorder

United States
Mclean Hospital

Completed

Neuroimaging Studies of Reward Processing in Depression

Major Depressive Disorder

United States
University of Cincinnati
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults

Bipolar Disorder | Alcohol Abuse

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Loxapine Pulmonary Safety in Patients With COPD

Chronic Obstructive Pulmonary Disease

United States
Gerald Maguire, MD
University of California Riverisde School of Medicine

Unknown

Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).

Language Disorders | Speech Disorders | Communication Disorder | Stuttering, Adult | Childhood-onset Fluency Disorder

United States
Anders Fink-Jensen, MD, DMSci
Rigshospitalet, Denmark; University of Copenhagen

Completed

The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.

Schizophrenia

Denmark
Assistance Publique - Hôpitaux de Paris

Completed

Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning (Sevralox)

Restlessness

France
CHA University
Handok Inc.

Unknown

Association of Amisulpride Response in Schizophrenia With Brain Image (ARB)

Schizophrenia | Schizophreniform Disorder
Sanofi

Completed

Amisulpride in Schizophrenic Acute Phase Patients (ASAP)

Schizophrenia

Hong Kong
Holly Swartz
National Institute of Mental Health (NIMH)

Completed

Acute Psychotherapy for Bipolar II Depression

Depression | Bipolar Disorder

United States
Galera Therapeutics, Inc.

Terminated

Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC (GRECO-1)

NSCLC | SBRT | Non-metastatic

United States
Inje University

Unknown

The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope

Major Depressive Disorder

Korea, Republic of
Organon and Co

Completed

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)

Bipolar Disorder, Pediatric
Sanofi

Completed

Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia (ESCAPE)

Schizophrenia

China
Soonchunhyang University Hospital
Pfizer

Completed

Effectiveness of Ziprasidone for Patients With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Korea, Republic of
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Psychotic Disorders | Schizophrenia | Emergency Treatment
Shanghai Mental Health Center

Completed

The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia

Schizophrenia

China
ACADIA Pharmaceuticals Inc.

Active, not recruiting

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

Schizophrenia

Ukraine, Argentina, Bulgaria, Croatia, Czechia, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, United States, Canada
Lyndra Inc.

Completed

Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005

Schizophrenia | Schizoaffective Disorder

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia (RISE)

Schizophrenia

United States, Bulgaria
ACADIA Pharmaceuticals Inc.

Terminated

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Adjunctive Treatment of Major Depressive Disorder

United States, Serbia, Finland, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
ACADIA Pharmaceuticals Inc.

Completed

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

Treatment of Depression in Adults With Parkinson's Disease (PD)

United States
Intra-Cellular Therapies, Inc.

Completed

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

Schizophrenia

United States
National Institute on Drug Abuse (NIDA)
New York State Psychiatric Institute

Completed

Cocaine Abuse and ADHD - 10

Cocaine-Related Disorders

United States
Tufts Medical Center
Pfizer

Completed

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

Depression | Bipolar Disorder | Bipolar Depression

United States
Centre for Addiction and Mental Health
The Ian Douglas Bebensee Foundation

Completed

Switching Antipsychotics: Abrupt Discontinuation Versus Overlap

Schizophrenia | Schizoaffective Disorder

Canada
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia

Schizophrenia

China
GlaxoSmithKline

Completed

Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

Schizophrenia

United States
Duke University
Janssen, LP

Completed

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

Schizophrenia | Schizoaffective Disorder

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis

Schizophrenia
The University of Texas Health Science Center at...
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center

Schizophrenia | Schizoaffective

United States
University of Zurich
H. Lundbeck A/S; University Hospital of Psychiatry, Department Neuropsychopharmacology...

Terminated

The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients

Schizophrenia

Switzerland
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

Anxiety Disorders
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.

Bipolar Disorder

Search clinical trials for: Antipsychotic Agents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations